← Eichor
Study identifier: NCT06828185 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy

Condition: Testicular Cancer  ·  Sponsor: Loma Linda University

PhaseNA
Planned participants80
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the difference in patient-reported postoperative outcomes between two standard-of-care surgical techniques for radical orchiectomy (inguinal orchiectomy versus external oblique fascia sparing orchiectomy) for treatment of patients with suspected testicular malignancy. The main questions it aims to answer are: 1. Does sparing the external oblique fascia during orchiectomy reduce pain after surgery? 2. Is there a difference in narcotic consumption after surgery? 3. Is there a difference in neuropathic pain after surgery? 4. Is there a difference in complications after surgery?

This description comes directly from the study's public registry record.

Talk to the study team

Muhannad Alsyouf, MD  ·  9095584000  ·  Malsyouf@llu.edu

Brian Hu, MD  ·  9095584000  ·  Bhu@llu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Loma Linda UniversityLoma Linda, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06828185